Full Professor(heuristic)

Bladder and Urothelial Cancer Treatments · Surgery

Compare more Surgery professors.

h-index106
i10-index282
Publications814
Citations89,585

Grants

3 total · 0 active

NIH #P01CA221757

Core A: Molecular Pathology Core

Amount
$300K–$400K
Period
2018-09-11 → 2024-08-31
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #R01CA233899

Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma

Amount
$400K–$500K
Period
2019-02-01 → 2024-01-31
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #P50CA221745

Biospecimen Repository Core

Amount
$200K–$300K
Period
— → —
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

3 total · 0 active

NIH #P01CA221757

Core A: Molecular Pathology Core

Amount
$300K–$400K
Period
2018-09-11 → 2024-08-31
PIs
1

Awarded at COLUMBIA UNIVERSITY HEALTH SCIENCES

NIH #R01CA233899

Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma

Amount
$400K–$500K
Period
2019-02-01 → 2024-01-31
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #P50CA221745

Biospecimen Repository Core

Amount
$200K–$300K
Period
— → —
PIs
1

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Recent Public Signals

  1. New paper: Data from Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer2026-06-17

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-2938-6627

Professor Insights

Career Trajectory